Why the study?
Does controlled hypoglycemia to 60 mg/dL during an insulin tolerance test cause clinically significant QT prolongation in healthy male subjects?
Does controlled hypoglycemia to 60 mg/dL during an insulin tolerance test cause clinically significant QT prolongation in healthy male subjects?
Answers are grounded in this paper and cite their sources.
Controlled hypoglycemia to 60 mg/dL during an insulin tolerance test is unlikely to cause clinically significant QT prolongation in healthy subjects, suggesting continuous ECG monitoring is not warranted.
OBJECTIVES: A modified insulin tolerance test (ITT) can be used to simulate a physiological stress state through the induction of controlled hypoglycemia in healthy volunteers. This allows for evaluation of hypothalamic-pituitary-adrenocortical axis response to stress via a surge in cortical release. However, a consequence of severe, prolonged hypoglycemia is QT interval prolongation. The aim of this analysis was to confirm that blood glucose lowering to 60 mg/dL (previously identified as adequate for inducing stress) has low risk of inducing clinically significant QT prolongation. MATERIALS AND METHODS: Continuous ECG monitoring was conducted as a planned sub study of an open-label, 2-period study involving 18 healthy male subjects. The QTcF response to hypoglycemia was measured over 2 identical periods, ~ 7 days apart. RESULTS: An indirect- response model adequately described the pharmacological relationship between blood glucose and QTcF intervals over the time-course of the ITT. The model correctly identified the steep glucose-QT relationship as an on-off response with a large Hill coefficient of 59 and the threshold glucose, EC50, as ~ 57 mg/dL with narrow between-subject variability of 10%. Simulated QTcF profiles over the course of an ITT did not demonstrate any QTcF interval changes of clinical concern, defined as QTcF observation > 500 ms, if hypoglycemia did not reach below 60 mg/dL. The statistical prediction that the chance of a mean QTcF observation > 500 ms was < 0.0001. CONCLUSIONS: Results support that an ITT maintained at or above 60 mg/dL is unlikely to cause QT prolongation in healthy volunteers and does not warrant continuous ECG monitoring in this group of subjects.
No takes yet. Share an insight, caveat, or question.
Tham et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: